Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 16,465.4 million compared to INR 18,521.2 million a year ago. Revenue was INR 17,519.2 million compared to INR 19,217.9 million a year ago. Net income was INR 3,724.7 million compared to INR 4,942.8 million a year ago. Basic earnings per share from continuing operations was INR 81.42 compared to INR 108.04 a year ago. Diluted earnings per share from continuing operations was INR 81.42 compared to INR 108.04 a year ago.